So, the natural question for Cartesian Therapeutics (NASDAQ:RNAC) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual ...

Extraordinary General Meeting of Shareholders to Approve Business Combination Scheduled for May 27, 2026BOSTON and NEW YORK, ...

Bounteous, an AI services firm, today announced its acquisition of Cartesian, a specialist consulting firm focused on the ...

Detailed price information for Cartesian Growth Corporation III Cl A (CGCT-Q) from The Globe and Mail including charting and trades.

The 72-year-old writer and pop culture legend is set to hand in the second book in his praised fantasy series.

The myasthenia gravis market size reached approximately USD 6 billion in 2025 across the 7MM and is growing at a robust CAGR of 9.1% during the forecast period. This remarkable growth is being ...

Picnics divide opinion. Some believe that no meal banishes quotidian concerns like an al-fresco lunch. Others decry the ...

View Cartesian Growth Corp. III Class A CGCT stock quote prices, financial information, real-time forecasts, and company news from CNN.

Enrollment continues to progress in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis Phase 2 TRITON trial of Descartes-08 in ...

Detailed price information for Biomarin Pharmaceuticals (BMRN-Q) from The Globe and Mail including charting and trades.

My prank demonstrated how our minds can adversely affect our health, and scientists are increasingly showing that negative thoughts can produce very real symptoms, says science writer Helen Pilcher ...